ARCHIVES

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

This article is from The Cancer Letter archive.

Vol. 25 No. 21 | May 28, 1999

Download PDF Visit The Full Archive

Related Articles

Brigid Levental, Pediatric researcher, Dead At 58

February 18, 1994

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

November 29, 2002

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

DCPC Board Approves Concepts For New Master Agreement, Recompetitions

October 9, 1987